Biopharmaceutical Contract Manufacturing Market 2027 By Product, Therapeutic Application | The Insight Partners

Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Interferon, Monoclonal Antibodies, Recombinant Hormone, Proteins, Vaccines, Vitamins, Insulin, Others); Therapeutic Application (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others)

Report Code: TIPRE00005512 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Biopharmaceutical Contract Manufacturing refers to development and manufacturing of biopharmaceutical molecules, proteins, nucleic acids, blood component and vaccines developed from biological source.

MARKET DYNAMICS
The Biopharmaceutical Contract Manufacturing market is anticipated to grow in the forecast, owing to the factors such as risk of fencing nature of biopharmaceutical companies through outsourcing manufacturing to CMOs, strong technical abilities and greater flexibility offered by CMOs. Nevertheless, lack of capacity of CMOs to manufacture large volume biopharmaceutical drugs is expected to hamper the growth of market during the forecast period.

MARKET SCOPE
The "Global Biopharmaceutical Contract Manufacturing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Biopharmaceutical Contract Manufacturing market with detailed market segmentation by product, therapeutic application and geography. The global Biopharmaceutical Contract Manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biopharmaceutical Contract Manufacturing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Biopharmaceutical Contract Manufacturing market is segmented on the basis of product and therapeutic application. Based on product the market is segmented into Interferon, Monoclonal Antibodies, Recombinant Hormone, Proteins, Vaccines, Vitamins, Insulin, Others. Based on therapeutic application the market is segmented into Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biopharmaceutical Contract Manufacturing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Biopharmaceutical Contract Manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Biopharmaceutical Contract Manufacturing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Biopharmaceutical Contract Manufacturing market in these regions.

MARKET PLAYERS
The reports cover key developments in the Biopharmaceutical Contract Manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Biopharmaceutical Contract Manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for Biopharmaceutical Contract Manufacturing market in the global market. Below mentioned is the list of few companies engaged in the Biopharmaceutical Contract Manufacturing market.

The report also includes the profiles of Biopharmaceutical Contract Manufacturing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Lonza
  • Cytovance Biologics
  • FUJIFILM Corporation
  • Rentschler Biopharma SE
  • GE
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Pfizer Inc
  • ProBioGen AG
  • Thermo Fisher Scientific Inc
  • TOYOBO CO., LTD.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical Contract Manufacturing Market - By Product
1.3.2 Biopharmaceutical Contract Manufacturing Market - By Therapeutic Application
1.3.3 Biopharmaceutical Contract Manufacturing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL CONTRACT MANUFACTURING - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL CONTRACT MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INTERFERON
7.3.1. Overview
7.3.2. Interferon Market Forecast and Analysis
7.4. MONOCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Monoclonal Antibodies Market Forecast and Analysis
7.5. RECOMBINANT HORMONE
7.5.1. Overview
7.5.2. Recombinant Hormone Market Forecast and Analysis
7.6. PROTEINS
7.6.1. Overview
7.6.2. Proteins Market Forecast and Analysis
7.7. VACCINES
7.7.1. Overview
7.7.2. Vaccines Market Forecast and Analysis
7.8. VITAMINS
7.8.1. Overview
7.8.2. Vitamins Market Forecast and Analysis
7.9. INSULIN
7.9.1. Overview
7.9.2. Insulin Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC APPLICATION
8.1. OVERVIEW
8.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. AUTOIMMUNE DISEASES
8.4.1. Overview
8.4.2. Autoimmune Diseases Market Forecast and Analysis
8.5. METABOLIC DISEASES
8.5.1. Overview
8.5.2. Metabolic Diseases Market Forecast and Analysis
8.6. CARDIOVASCULAR DISEASES
8.6.1. Overview
8.6.2. Cardiovascular Diseases Market Forecast and Analysis
8.7. NEUROLOGY
8.7.1. Overview
8.7.2. Neurology Market Forecast and Analysis
8.8. INFECTIOUS DISEASES
8.8.1. Overview
8.8.2. Infectious Diseases Market Forecast and Analysis
8.9. OTHERS.
8.9.1. Overview
8.9.2. Others. Market Forecast and Analysis
9. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biopharmaceutical Contract Manufacturing Market Overview
9.1.2 North America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis
9.1.3 North America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Product
9.1.4 North America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Therapeutic Application
9.1.5 North America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biopharmaceutical Contract Manufacturing Market
9.1.5.1.1 United States Biopharmaceutical Contract Manufacturing Market by Product
9.1.5.1.2 United States Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.1.5.2 Canada Biopharmaceutical Contract Manufacturing Market
9.1.5.2.1 Canada Biopharmaceutical Contract Manufacturing Market by Product
9.1.5.2.2 Canada Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.1.5.3 Mexico Biopharmaceutical Contract Manufacturing Market
9.1.5.3.1 Mexico Biopharmaceutical Contract Manufacturing Market by Product
9.1.5.3.2 Mexico Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.1.5.4 US Biopharmaceutical Contract Manufacturing Market
9.1.5.4.1 US Biopharmaceutical Contract Manufacturing Market by Product
9.1.5.4.2 US Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.2. EUROPE
9.2.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
9.2.2 Europe Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis
9.2.3 Europe Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Product
9.2.4 Europe Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Therapeutic Application
9.2.5 Europe Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biopharmaceutical Contract Manufacturing Market
9.2.5.1.1 Germany Biopharmaceutical Contract Manufacturing Market by Product
9.2.5.1.2 Germany Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.2.5.2 France Biopharmaceutical Contract Manufacturing Market
9.2.5.2.1 France Biopharmaceutical Contract Manufacturing Market by Product
9.2.5.2.2 France Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.2.5.3 Italy Biopharmaceutical Contract Manufacturing Market
9.2.5.3.1 Italy Biopharmaceutical Contract Manufacturing Market by Product
9.2.5.3.2 Italy Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.2.5.4 Spain Biopharmaceutical Contract Manufacturing Market
9.2.5.4.1 Spain Biopharmaceutical Contract Manufacturing Market by Product
9.2.5.4.2 Spain Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.2.5.5 United Kingdom Biopharmaceutical Contract Manufacturing Market
9.2.5.5.1 United Kingdom Biopharmaceutical Contract Manufacturing Market by Product
9.2.5.5.2 United Kingdom Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Overview
9.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis
9.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Therapeutic Application
9.3.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biopharmaceutical Contract Manufacturing Market
9.3.5.1.1 Australia Biopharmaceutical Contract Manufacturing Market by Product
9.3.5.1.2 Australia Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.3.5.2 China Biopharmaceutical Contract Manufacturing Market
9.3.5.2.1 China Biopharmaceutical Contract Manufacturing Market by Product
9.3.5.2.2 China Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.3.5.3 India Biopharmaceutical Contract Manufacturing Market
9.3.5.3.1 India Biopharmaceutical Contract Manufacturing Market by Product
9.3.5.3.2 India Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.3.5.4 Japan Biopharmaceutical Contract Manufacturing Market
9.3.5.4.1 Japan Biopharmaceutical Contract Manufacturing Market by Product
9.3.5.4.2 Japan Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.3.5.5 South Korea Biopharmaceutical Contract Manufacturing Market
9.3.5.5.1 South Korea Biopharmaceutical Contract Manufacturing Market by Product
9.3.5.5.2 South Korea Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Overview
9.4.2 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis
9.4.3 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Therapeutic Application
9.4.5 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biopharmaceutical Contract Manufacturing Market
9.4.5.1.1 South Africa Biopharmaceutical Contract Manufacturing Market by Product
9.4.5.1.2 South Africa Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.4.5.2 Saudi Arabia Biopharmaceutical Contract Manufacturing Market
9.4.5.2.1 Saudi Arabia Biopharmaceutical Contract Manufacturing Market by Product
9.4.5.2.2 Saudi Arabia Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.4.5.3 U.A.E Biopharmaceutical Contract Manufacturing Market
9.4.5.3.1 U.A.E Biopharmaceutical Contract Manufacturing Market by Product
9.4.5.3.2 U.A.E Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biopharmaceutical Contract Manufacturing Market Overview
9.5.2 South and Central America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis
9.5.3 South and Central America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Product
9.5.4 South and Central America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Therapeutic Application
9.5.5 South and Central America Biopharmaceutical Contract Manufacturing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biopharmaceutical Contract Manufacturing Market
9.5.5.1.1 Brazil Biopharmaceutical Contract Manufacturing Market by Product
9.5.5.1.2 Brazil Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
9.5.5.2 Argentina Biopharmaceutical Contract Manufacturing Market
9.5.5.2.1 Argentina Biopharmaceutical Contract Manufacturing Market by Product
9.5.5.2.2 Argentina Biopharmaceutical Contract Manufacturing Market by Therapeutic Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET, KEY COMPANY PROFILES
11.1. LONZA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CYTOVANCE BIOLOGICS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FUJIFILM CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. RENTSCHLER BIOPHARMA SE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GE
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. VETTER PHARMA-FERTIGUNG GMBH AND CO. KG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROBIOGEN AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. THERMO FISHER SCIENTIFIC INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TOYOBO CO., LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Lonza
- Cytovance Biologics
- FUJIFILM Corporation
- Rentschler Biopharma SE
- GE
- Vetter Pharma-Fertigung GmbH & Co. KG
- Pfizer Inc
- ProBioGen AG
- Thermo Fisher Scientific Inc
- TOYOBO CO., LTD.